Bryan F. Cox
Chief of Research @ TriSalus Life Sciences
About
Nephraegis Therapeutics (Nephros = kidney, Aegis = shield) is an early stage biotechnology company dedicated to discovering and developing novel therapeutics for patients with renal disease. Renal disease has a major impact on patients and the heathcare system – with limited options for treatment. Working with our academic partners at Medical College of Wisconsin and University of Texas Southwestern, Nephraegis Therapeutics is exploring the pharmacologic potential of two families of epoxyeicosanoids (patents issued). Our lead compound NPH-022 is targeted to treat Acute Kidney Injury (AKI), a major renal disease state with no approved pharmacologic treatment. NPH-022 has been demonstrated to have efficacy and excellent pharmacokinetics in preclinical models. In addition, Nephraegis Therapeutics is continuing to discover novel compounds to be used in treating multiple other renal disease states.
United States
Lake Forest
Pharmaceuticals
Drug Development, Pharmacology, Pharmaceutical Industry, Clinical Development, Drug Discovery, Translational Medicine, Biotechnology, Life Sciences, CRO, R&D, Biopharmaceuticals, Biomarker Discovery, Pharmaceutical Research, Technology Transfer, Regulatory Submissions, Neuroscience, Oncology, Antibacterial, Immunology, Cardiology
Experience

CEO
Nephraegis Therapeutics
Lake Forest, IL

President
CoPharm Global Consulting

President
Helping Hands Food Pantry
Spring Grove IL
Volunteer organization providing for the less fortunate in the Spring Grove IL area. Presently serving as President (2014 - present). Provide leadership and budgetary direction allowing the Pantry to feed 100 to 120 families per week.

Director (Retired)
United States
ABBOTT LABORATORIES / ABBVIE, Abbott Park, IL 1996 to 2013 Director, Integrative Pharmacology, Global Pharmaceutical Research and Development 2003 to 2013 (17 Senior Staff, 23 B.S./M.S., 2 Post-Docs, 1 Admin.) Lead a diversified pharmacology unit which provided pivotal datasets enabling advancement of Discovery compounds into early Clinical Development. • Served as a member of the Discovery Leadership Team responsible for the scientific direction, budget, and promotions for 975 employees across multiple international research sites. • Initiated and established a new research area (Renal) leveraging global academic collaborations, selected contract research organizations, and focused internal resources to advance new pharmacologic targets. • Represented Discovery on the Renal Therapeutic Area Executive Committee (Discovery, Clinical Development, Regulatory, Marketing, and Commercial). • Chosen as the GPRD Leader for the Grants and Donations Workstream • Appointed as a Charter member of the Technical Assessment Team for Abbott BioVentures (Venture Capital Arm for pharmaceutical investments – Preclinical lead on a Series A financing). • Major contributions to numerous in-licensing and acquisition opportunities. Senior Group / Project /Senior Project Leader, Integrative Pharmacology 1996 to 2003 Responsible for safety pharmacology profile for all compounds in Abbott’s late Discovery portfolio. • Authored or approved hundreds of R&D reports for Regulatory submission. • Provided Discovery leadership for both efficacy and safety pharmacology as one of three Abbott representatives on the Abbott/BioRex Collaborative R&D Committee. • Significantly increased the Translational Medicine capabilities of Abbott Discovery by expanding Preclinical Imaging both in technological capabilities and headcount. • Managed capital budgets for new technology acquisition and facility renovations.

Associate Research Fellow
Rhone Poulenc Rorer
United States
Senior Research Scientist, Associate Research Fellow Managed a team of scientists responsible for defining the potential CardioRenal applications for a series of selective adenosine agonists. Identified/validated a set of novel targets in the heart failure and/or peripheral vascular disease space.
Bryan F. Cox's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.




